遺伝子発現解析市場：製品（試薬、酵素、キット、DNAチップ、PCR、NGS、DNAマイクロアレイ）、サービス（RNAシーケンス、バイオインフォマティクス）、用途（創薬・開発、臨床診断）、エンドユーザー別 - 2029年までの世界予測

Gene Expression Analysis Market by Product (Reagents, Enzymes, kits, DNA Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Bioinformatics), Application (Drug discovery & development, clinical diagnostics), End User - Global Forecast to 2029

遺伝子発現解析市場は、予測期間中の年平均成長率8.1%で、2024年の推定42億米ドルから2029年には62億米ドルに達すると予測されている。この市場の成長は、ゲノミクス研究への投資が増加していることに起因して... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2024年3月12日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	370	490	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

遺伝子発現解析市場は、予測期間中の年平均成長率8.1%で、2024年の推定42億米ドルから2029年には62億米ドルに達すると予測されている。
この市場の成長は、ゲノミクス研究への投資が増加していることに起因していると考えられ、遺伝子研究に対する政府からの資金援助が利用可能であることも、市場の拡大にさらに寄与している。遺伝子制御と分子メカニズムの理解が深まり、この分野が進化し続けるにつれて、遺伝子発現解析市場は継続的な成長と革新の態勢を整えている。
"2023年、機器別ではPCR機器セグメントが最大シェアを占める"
2023年、世界の遺伝子発現解析市場において、PCR装置は製品＆サービスの装置サブセグメントで最大のシェアを占めた。PCR装置は、製薬、バイオテクノロジー、学術研究、臨床診断、法医学を含む様々な産業で広く採用されている。この幅広い応用範囲がPCR装置の大きな市場シェアに寄与している。
""アジア太平洋地域は、2024-2029年の予測期間中、遺伝子発現解析市場で最も高いCAGRで成長する""
アジア太平洋地域は予測期間中に最も高い成長率で成長すると予測されている。この地域は、プロテオミクスやゲノミクス研究の拡大、研究資金の増強、製薬企業やバイオテクノロジー企業からの投資の拡大、個別化治療薬を取り巻く意識の高まりに後押しされ、急速な成長が見込まれている。アジア太平洋地域では、特にインドと中国が最も高い成長を示すと予想されており、その理由は手頃な価格の上昇と診断の利点に関する意識の高まりによるものである。
本レポートのために実施した一次インタビューは以下のように分類できる：

- 回答者別供給側70％、需要側30
- 役職別管理職 - 45%、CXOおよび取締役 - 30%、経営幹部 - 25
- 地域別北米45％、欧州20％、アジア太平洋地域20％、中南米10％、中東・アフリカ5
レポート掲載企業一覧
- サーモフィッシャーサイエンティフィック（米国）
- バイオ・ラッド・ラボラトリーズ社（米国）
- イルミナ社（米国）
- QIAGEN (オランダ)
- F.ホフマン・ラ・ロシュ（スイス）
- レビティ（米）
- パックバイオ（米）
- アジレント・テクノロジー（米国）
- オックスフォード・ジーン・テクノロジーIP社（英国）
- BGI（中国）
- ユーロフィンズサイエンティフィック（ルクセンブルク）
- スタンダード・バイオツールズ（米国）
- オックスフォード・ナノポア・テクノロジーズ（英国）
- ジェンスクリプト（米国）
- タカラバイオ（日本）
- 10x Genomics（米国）
- ザイモ・リサーチ・コーポレーション（米）
- ツイスト・バイオサイエンス（米）
- プロメガ・コーポレーション（米）
- LGCリミテッド（英国）
- CDジェノミクス（米国）
- ナノストリング・テクノロジーズ（米）
- バイオスパイダー（米）
- インテグレーテッドDNAテクノロジーズ（米）
- New England Biolabs（米国）。

調査範囲
この調査レポートは、遺伝子発現解析市場を製品＆サービス（機器、試薬＆消耗品、サービス（遺伝子発現解析サービス、バイオインフォマティクスサービス））、アプリケーション（臨床診断、創薬＆開発、その他のアプリケーション（発生生物学、薬理ゲノミクス、環境対応、法医学研究、農業研究））、エンドユーザー（製薬＆バイオテクノロジー企業、学術＆研究機関、その他のエンドユーザー（臨床研究所、CRO、法医学研究所、農業＆環境団体））、地域別（北米、欧州、アジア太平洋、中南米、中東、アフリカ）。本レポートでは、遺伝子発現解析市場の成長に影響を与える促進要因、課題、機会、動向などの主要要因に関する詳細情報を網羅しています。本レポートでは、主要な業界プレイヤーを詳細に分析し、そのビジネスプロフィール、製品/サービスの提供、および遺伝子発現解析市場における提携、パートナーシップ、事業拡大、合意、買収、最近の開発などの戦略的イニシアティブに関する洞察を提供しています。さらに、遺伝子発現解析市場のエコシステムにおける主要企業や新興新興企業の競合分析も網羅しています。
レポート購入の主な利点
本レポートは、遺伝子発現解析市場全体とそのサブセグメントにおける収益数の最も近い概算値を提供することで、市場リーダーや新規参入者を支援します。また、利害関係者が競合状況をより良く理解し、より多くの洞察を得ることで、自社のビジネスをより良く位置づけ、適切な市場参入戦略を立てるのに役立ちます。本レポートは、利害関係者が市場の脈動を理解し、主要な市場促進要因、阻害要因、機会、および課題に関する情報を提供することを可能にします。
本レポートは、以下のポイントに関する洞察を提供します：
- 市場の成長に影響を与える主要な促進要因（遺伝子編集技術の進歩、ゲノム研究に対する資金提供の増加、治療への応用に対する嗜好の高まり、シーケンスコストの低下）、阻害要因（機器・消耗品の高コスト、データプライバシーとセキュリティに関する懸念）、機会（非医療分野での応用拡大、機械学習とAI、シングルセル解析への注目の高まり）、課題（承認までのタイムラインの長期化、データ解釈の課題）の分析。
- 製品開発/イノベーション：遺伝子発現解析市場の新製品に関する詳細な洞察
- 市場開発：有利な市場に関する包括的な情報 - 当レポートでは様々な地域の市場を分析しています。
- 市場の多様化：遺伝子発現解析市場における新製品/サービス、未開拓地域、最近の開発、投資に関する詳細情報
- 競合他社の評価サーモフィッシャーサイエンティフィック社（米国）、バイオラッドラボラトリーズ社（米国）、イルミナ社（米国）、QIAGEN社（オランダ）、F.Hoffmann-La Roche（スイス）、Revvity（米国）、PacBio（米国）、Agilent Technologies Inc（米国）、Oxford Gene Technology IP Limited（英国）、BGI（中国）、Eurofins Scientific（ルクセンブルク）、Standard BioTools（米国）、Oxford Nanopore Technologies plc（英国）、GenScript（米国）、タカラバイオ（日本）、10x Genomics（米国）、Zymo Research Corporation（米国）、Twist Bioscience（米国）、Promega Corporation（米国）、LGC Limited（英国）、CD Genomics（米国）、NanoString Technologies Inc.(米国）、BioSpyder, Inc（米国）、Integrated DNA Technologies, Inc（米国）、New England Biolabs（米国）などである。

ページTOPに戻る

1 INTRODUCTION 31
1.1 STUDY OBJECTIVES 31
1.2 MARKET DEFINITION 31
1.2.1 INCLUSIONS & EXCLUSIONS 31
1.3 MARKET SCOPE 32
1.3.1 MARKETS COVERED 32
1.3.2 REGIONS COVERED 33
1.3.3 YEARS CONSIDERED 33
1.3.4 CURRENCY CONSIDERED 34
1.4 RESEARCH LIMITATIONS 34
1.5 STAKEHOLDERS 34
1.6 SUMMARY OF CHANGES 35
1.7 RECESSION IMPACT 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DATA 36
FIGURE 1 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 37
2.1.2 PRIMARY DATA 38
FIGURE 2 GENE EXPRESSION ANALYSIS MARKET: BREAKDOWN OF PRIMARIES 38
2.2 MARKET SIZE ESTIMATION 39
FIGURE 3 MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023 39
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2023 40
FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2023 40
2.2.1 INSIGHTS FROM PRIMARIES 42
FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS 42
2.2.2 SEGMENT ASSESSMENT (BY PRODUCT & SERVICE, APPLICATION, AND END USER) 42
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 42
2.3 GROWTH RATE ASSUMPTIONS 43
FIGURE 8 GENE EXPRESSION ANALYSIS MARKET: CAGR PROJECTIONS (2024–2029) 44
FIGURE 9 GENE EXPRESSION ANALYSIS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES 44
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 45
FIGURE 10 DATA TRIANGULATION METHODOLOGY 45
2.5 STUDY ASSUMPTIONS 46
2.6 RISK ANALYSIS 46
2.7 RECESSION IMPACT ANALYSIS 46
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2024–2028 (% GROWTH) 47
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 47
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION) 47
3 EXECUTIVE SUMMARY 48
FIGURE 11 GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD MILLION) 48
FIGURE 12 GENE EXPRESSION SERVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 49
FIGURE 13 GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 49
FIGURE 14 GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 50
FIGURE 15 GEOGRAPHIC SNAPSHOT OF GENE EXPRESSION ANALYSIS MARKET 51
4 PREMIUM INSIGHTS 52
4.1 GENE EXPRESSION ANALYSIS MARKET OVERVIEW 52
FIGURE 16 ADVANCEMENTS IN GENE EDITING TECHNOLOGIES TO DRIVE MARKET 52
4.2 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2023 53
FIGURE 17 PRODUCT & SERVICE SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 53
4.3 GENE EXPRESSION ANALYSIS MARKET SHARE, BY PRODUCT & SERVICE, 2024 VS. 2029 53
FIGURE 18 PRODUCT & SERVICE SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 53
4.4 GENE EXPRESSION ANALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 54
FIGURE 19 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
FIGURE 20 GENE EXPRESSION ANALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55
5.2.1 DRIVERS 56
5.2.1.1 Advancements in gene editing technologies 56
5.2.1.2 Increasing funding initiatives for genomic research 57
5.2.1.3 Growing preference for therapeutic applications 57
5.2.1.4 Declining costs of sequencing technologies 58
FIGURE 21 COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001–2022 59
5.2.2 RESTRAINTS 59
5.2.2.1 High cost of instruments & consumables 59
5.2.2.2 Concerns associated with data privacy and security 60
5.2.3 OPPORTUNITIES 61
5.2.3.1 High growth potential across non-clinical applications 61
5.2.3.2 Machine learning and AI 62
5.2.3.3 Growing focus on single-cell analysis 63
5.2.4 CHALLENGES 64
5.2.4.1 Extensive timelines for product approval 64
5.2.4.2 Data interpretation challenges 64
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 65
FIGURE 22 REVENUE SHIFT TOWARDS GENE EXPRESSION ANALYSIS COMPANIES 65
5.4 PRICING ANALYSIS 66
5.4.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT 66
TABLE 4 GENE EXPRESSION ANALYSIS PRODUCT PRICE 66
5.5 VALUE CHAIN ANALYSIS 67
FIGURE 23 GENE EXPRESSION ANALYSIS MARKET: VALUE CHAIN ANALYSIS 68
5.6 SUPPLY CHAIN ANALYSIS 69
FIGURE 24 GENE EXPRESSION ANALYSIS MARKET: SUPPLY CHAIN ANALYSIS 69
TABLE 5 GENE EXPRESSION ANALYSIS MARKET: SUPPLY CHAIN ANALYSIS 70
5.7 ECOSYSTEM ANALYSIS 71
FIGURE 25 GENE EXPRESSION ANALYSIS MARKET ECOSYSTEM 71
5.7.1 GENE EXPRESSION ANALYSIS MARKET: REAGENT & CONSUMABLE VENDORS 72
TABLE 6 GENE EXPRESSION ANALYSIS MARKET: REAGENT & CONSUMABLE VENDORS 72
5.7.2 GENE EXPRESSION ANALYSIS MARKET: INSTRUMENT VENDORS 72
TABLE 7 GENE EXPRESSION ANALYSIS MARKET: INSTRUMENT VENDORS 72
5.7.3 GENE EXPRESSION ANALYSIS MARKET: END USERS 73
TABLE 8 GENE EXPRESSION ANALYSIS MARKET: END USERS 73
5.7.4 GENE EXPRESSION ANALYSIS MARKET: REGULATORY BODIES 73
TABLE 9 GENE EXPRESSION ANALYSIS MARKET: REGULATORY BODIES 73
5.8 TECHNOLOGY ANALYSIS 74
5.9 PATENT ANALYSIS 75
5.9.1 PATENTS FILED, BY DOCUMENT TYPE, 2014–2024 75
TABLE 10 PATENTS FILED, 2014–2024 75
5.9.2 INNOVATION & PATENT APPLICATIONS 75
FIGURE 26 TOTAL NUMBER OF PATENTS GRANTED, 2014–2023 75
5.9.3 TOP APPLICANTS 76
FIGURE 27 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014–2024 76
FIGURE 28 REGIONAL ANALYSIS OF PATENTS GRANTED, 2014–2024 76
TABLE 11 TOP 12 PATENT OWNERS IN GENE EXPRESSION ANALYSIS MARKET, 2014–2024 77
TABLE 12 PATENTS IN GENE EXPRESSION ANALYSIS MARKET (2024) 77
5.10 TRADE DATA 79
5.10.1 INSTRUMENTS & APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS 79
TABLE 13 IMPORT VOLUME FOR INSTRUMENTS & APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS (HS CODE-902780), 2018–2022 (TONS) 80
TABLE 14 EXPORT VOLUME FOR INSTRUMENTS & APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS (HS CODE-902780), 2018–2022 (TONS) 80
5.10.2 MICROTOMES: PARTS & ACCESSORIES OF INSTRUMENTS AND APPARATUS FOR PHYSICAL/CHEMICAL ANALYSIS 81
TABLE 15 IMPORT VOLUME FOR MICROTOMES: PARTS & ACCESSORIES OF INSTRUMENTS AND APPARATUS FOR PHYSICAL/CHEMICAL ANALYSIS (HS CODE-902790), 2018–2022 (TONS) 81
TABLE 16 EXPORT VOLUME FOR MICROTOMES: PARTS & ACCESSORIES OF INSTRUMENTS AND APPARATUS FOR PHYSICAL/CHEMICAL ANALYSIS (HS CODE-902790), 2018–2022 (TONS) 81
5.11 KEY CONFERENCES & EVENTS 82
5.11.1 GENE EXPRESSION ANALYSIS MARKET: CONFERENCES & EVENTS IN 2024–2025 82
TABLE 17 GENE EXPRESSION ANALYSIS MARKET: CONFERENCES & EVENTS (2024–2025) 82
5.12 REGULATORY LANDSCAPE 83
5.12.1 CBER REGULATIONS ON GENE EXPRESSION ANALYSIS 83
5.12.2 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 18 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 19 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
TABLE 20 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86
TABLE 21 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87
5.13 PORTER’S FIVE FORCES ANALYSIS 88
TABLE 22 GENE EXPRESSION ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS 88
5.13.1 THREAT OF NEW ENTRANTS 88
5.13.2 THREAT OF SUBSTITUTES 89
5.13.3 BARGAINING POWER OF BUYERS 89
5.13.4 BARGAINING POWER OF SUPPLIERS 89
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 89
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 90
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 90
FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR GENE EXPRESSION ANALYSIS PRODUCTS & SERVICES 90
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR END USERS 90
5.14.2 BUYING CRITERIA FOR GENE EXPRESSION ANALYSIS PRODUCTS 91
FIGURE 30 KEY BUYING CRITERIA FOR END USERS 91
TABLE 24 KEY BUYING CRITERIA FOR TOP FOUR END USERS 91

6 GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE 93
6.1 INTRODUCTION 94
TABLE 25 GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 94
6.2 REAGENTS & CONSUMABLES 94
TABLE 26 GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 95
TABLE 27 GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2022–2029 (USD MILLION) 95
TABLE 28 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 96
TABLE 29 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 96
TABLE 30 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 97
TABLE 31 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 97
TABLE 32 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2022–2029 (USD MILLION) 97
TABLE 33 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 98
6.2.1 ASSAYS & KITS 98
6.2.1.1 Growing demand for streamlined and user-friendly solutions to drive market 98
TABLE 34 GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY REGION, 2022–2029 (USD MILLION) 99
TABLE 35 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022–2029 (USD MILLION) 99
TABLE 36 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022–2029 (USD MILLION) 100
TABLE 37 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022–2029 (USD MILLION) 100
TABLE 38 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022–2029 (USD MILLION) 101
TABLE 39 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY REGION, 2022–2029 (USD MILLION) 101
TABLE 40 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022–2029 (USD MILLION) 101
6.2.2 ENZYMES 102
6.2.2.1 High uptake in molecular techniques to drive market 102
TABLE 41 GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY REGION, 2022–2029 (USD MILLION) 102
TABLE 42 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION) 103
TABLE 43 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION) 103
TABLE 44 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION) 104
TABLE 45 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION) 104
TABLE 46 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY REGION, 2022–2029 (USD MILLION) 104
TABLE 47 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION) 105
6.2.3 DNA CHIPS 105
6.2.3.1 Rising demand across forensic research applications to propel market 105
TABLE 48 GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY REGION, 2022–2029 (USD MILLION) 106
TABLE 49 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY COUNTRY, 2022–2029 (USD MILLION) 106
TABLE 50 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY COUNTRY, 2022–2029 (USD MILLION) 107
TABLE 51 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY COUNTRY, 2022–2029 (USD MILLION) 107
TABLE 52 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY COUNTRY, 2022–2029 (USD MILLION) 108
TABLE 53 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY REGION, 2022–2029 (USD MILLION) 108
TABLE 54 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY COUNTRY, 2022–2029 (USD MILLION) 108
6.2.4 OTHER REAGENTS & CONSUMABLES 109
TABLE 55 GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY REGION, 2022–2029 (USD MILLION) 109
TABLE 56 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 110
TABLE 57 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 110
TABLE 58 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 111
TABLE 59 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 111
TABLE 60 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY REGION, 2022–2029 (USD MILLION) 111
TABLE 61 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 112
6.3 INSTRUMENTS 112
TABLE 62 GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 112
TABLE 63 GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION) 113
TABLE 64 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 113
TABLE 65 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 114
TABLE 66 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 114
TABLE 67 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 115
TABLE 68 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION) 115
TABLE 69 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 115
6.3.1 PCR 116
6.3.1.1 Growing focus on development of novel PCR kits to boost demand 116
TABLE 70 GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY REGION, 2022–2029 (USD MILLION) 117
TABLE 71 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION) 117
TABLE 72 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION) 118
TABLE 73 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION) 118
TABLE 74 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION) 119
TABLE 75 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY REGION, 2022–2029 (USD MILLION) 119
TABLE 76 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION) 119
6.3.2 NGS 120
6.3.2.1 Increasing investments in advanced technologies to drive market 120
TABLE 77 GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY REGION, 2022–2029 (USD MILLION) 120
TABLE 78 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY COUNTRY, 2022–2029 (USD MILLION) 121
TABLE 79 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY COUNTRY, 2022–2029 (USD MILLION) 121
TABLE 80 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY COUNTRY, 2022–2029 (USD MILLION) 122
TABLE 81 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY COUNTRY, 2022–2029 (USD MILLION) 122
TABLE 82 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY REGION, 2022–2029 (USD MILLION) 122
TABLE 83 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY COUNTRY, 2022–2029 (USD MILLION) 123
6.3.3 DNA MICROARRAYS 123
6.3.3.1 High-throughput capabilities to propel market 123
TABLE 84 GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY REGION, 2022–2029 (USD MILLION) 124
TABLE 85 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION) 124
TABLE 86 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION) 125
TABLE 87 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION) 125
TABLE 88 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 89 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY REGION 2022–2029 (USD MILLION) 126
TABLE 90 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION) 126
6.3.4 OTHER INSTRUMENTS 127
TABLE 91 GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION) 127
TABLE 92 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 128
TABLE 93 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 128
TABLE 94 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 129
TABLE 95 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 129
TABLE 96 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION) 129
TABLE 97 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 130
6.4 SERVICES 130
TABLE 98 GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 130
TABLE 99 GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY REGION, 2022–2029 (USD MILLION) 131
TABLE 100 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 131
TABLE 101 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 102 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 103 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 133
TABLE 104 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY REGION, 2022–2029 (USD MILLION) 133
TABLE 105 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 133
6.4.1 GENE EXPRESSION ANALYSIS SERVICES 134
TABLE 106 GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 134
6.4.1.1 RNA sequencing services 134
6.4.1.1.1 Rising technological advancements for drug discovery development to propel market 134
TABLE 107 GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY REGION, 2022–2029 (USD MILLION) 135
TABLE 108 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 109 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 136
TABLE 110 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 136
TABLE 111 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 137
TABLE 112 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY REGION, 2022–2029 (USD MILLION) 137
TABLE 113 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 137
6.4.1.2 Other services 138
TABLE 114 GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY REGION, 2022–2029 (USD MILLION) 138
TABLE 115 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 139
TABLE 116 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 139
TABLE 117 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 140
TABLE 118 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 140
TABLE 119 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY REGION, 2022–2029 (USD MILLION) 140
TABLE 120 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 141
6.4.2 BIOINFORMATICS SOLUTIONS 141
6.4.2.1 Increasing demand for advanced data analytics to support market growth 141
TABLE 121 GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY REGION, 2022–2029 (USD MILLION) 142
TABLE 122 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 142
TABLE 123 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 143
TABLE 124 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 143
TABLE 125 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 144
TABLE 126 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY REGION, 2022–2029 (USD MILLION) 144
TABLE 127 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 144
7 GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION 145
7.1 INTRODUCTION 146
TABLE 128 GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 146
7.2 DRUG DISCOVERY & DEVELOPMENT 146
7.2.1 INCREASING INVESTMENTS IN RNA-BASED THERAPEUTICS TO PROPEL MARKET 146
TABLE 129 GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION) 147
TABLE 130 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 147
TABLE 131 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 148
TABLE 132 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 148
TABLE 133 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 149
TABLE 134 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION) 149
TABLE 135 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 149
7.3 CLINICAL DIAGNOSTICS 150
7.3.1 RISING UTILIZATION OF MICROARRAYS FOR CANCER DETECTION TO DRIVE MARKET 150
TABLE 136 GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION) 151
TABLE 137 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION) 151
TABLE 138 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION) 152
TABLE 139 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION) 152
TABLE 140 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION) 153
TABLE 141 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION) 153
TABLE 142 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION) 153
7.4 OTHER APPLICATIONS 154
TABLE 143 GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 154
TABLE 144 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 145 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 146 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 156
TABLE 147 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 156
TABLE 148 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 157
TABLE 149 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 157
8 GENE EXPRESSION ANALYSIS MARKET, BY END USER 158
8.1 INTRODUCTION 159
TABLE 150 GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 159
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 159
8.2.1 GROWING FOCUS ON DEVELOPMENT OF TARGETED THERAPIES TO BOOST DEMAND 159
TABLE 151 GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 160
TABLE 152 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 160
TABLE 153 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 154 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 155 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 162
TABLE 156 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 162
TABLE 157 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 162
8.3 ACADEMIC & RESEARCH INSTITUTES 163
8.3.1 INCREASING GOVERNMENT-FUNDED INVESTMENTS TO PROPEL MARKET 163
TABLE 158 GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 164
TABLE 159 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 164
TABLE 160 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 165
TABLE 161 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 165
TABLE 162 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 166
TABLE 163 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 166
TABLE 164 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 166
8.4 OTHER END USERS 167
TABLE 165 GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION) 167
TABLE 166 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 168
TABLE 167 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 168
TABLE 168 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 169
TABLE 169 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 169
TABLE 170 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION) 170
TABLE 171 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 170
9 GENE EXPRESSION ANALYSIS MARKET, BY REGION 171
9.1 INTRODUCTION 172
TABLE 172 GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2022–2029 (USD MILLION) 172
9.2 NORTH AMERICA 173
FIGURE 31 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET SNAPSHOT 173
TABLE 173 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 174
TABLE 174 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 174
TABLE 175 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 174
TABLE 176 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 175
TABLE 177 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 175
TABLE 178 NORTH AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 175
TABLE 179 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 176
TABLE 180 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 176
9.2.1 NORTH AMERICA: RECESSION IMPACT 176
9.2.2 US 177
9.2.2.1 Rising expenditure on NGS-based research to drive market 177
TABLE 181 US: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 177
TABLE 182 US: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 178
TABLE 183 US: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 178
TABLE 184 US: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 178
TABLE 185 US: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 179
TABLE 186 US: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 179
TABLE 187 US: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 179
9.2.3 CANADA 180
9.2.3.1 Increasing incidence of chronic diseases to drive market 180
TABLE 188 CANADA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 180
TABLE 189 CANADA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 181
TABLE 190 CANADA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 181
TABLE 191 CANADA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 181
TABLE 192 CANADA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 182
TABLE 193 CANADA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 182
TABLE 194 CANADA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 182
9.3 EUROPE 183
TABLE 195 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 183
TABLE 196 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 184
TABLE 197 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 184
TABLE 198 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 184
TABLE 199 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 185
TABLE 200 EUROPE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 185
TABLE 201 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 185
TABLE 202 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 186
9.3.1 EUROPE: RECESSION IMPACT 186
9.3.2 GERMANY 186
9.3.2.1 Rising investments in proteomics & genomics research to drive market 186
TABLE 203 GERMANY: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 187
TABLE 204 GERMANY: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 188
TABLE 205 GERMANY: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 188
TABLE 206 GERMANY: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 188
TABLE 207 GERMANY: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 189
TABLE 208 GERMANY: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 189
TABLE 209 GERMANY: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 189
9.3.3 UK 190
9.3.3.1 Favorable government support for genomic research projects to fuel market 190
TABLE 210 UK: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 191
TABLE 211 UK: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 191
TABLE 212 UK: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 191
TABLE 213 UK: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 192
TABLE 214 UK: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 192
TABLE 215 UK: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 192
TABLE 216 UK: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 193
9.3.4 FRANCE 193
9.3.4.1 Increasing R&D in life sciences research to fuel market 193
TABLE 217 FRANCE: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 194
TABLE 218 FRANCE: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 194
TABLE 219 FRANCE: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 194
TABLE 220 FRANCE: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 195
TABLE 221 FRANCE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 195
TABLE 222 FRANCE: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 195
TABLE 223 FRANCE: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 196

ページTOPに戻る

Table of Contents

Summary

The gene expression analysis market is projected to reach USD 6.2 billion by 2029 from an estimated USD 4.2 billion in 2024, at a CAGR of 8.1% during the forecast period.
The growth of this market can be attributed to the growing investments in genomics research and the availability of government funding for genetic studies further contributes to the market's expansion. As the field continues to evolve, with a deeper understanding of gene regulation and molecular mechanisms, the gene expression analysis market is poised for continued growth and innovation.
“The PCR instrument segment accounted for the largest share by instruments in 2023.”
In 2023, the PCR segment accounted for the largest share of instruments sub-segment of product & service in the global gene expression analysis market. PCR instruments are widely adopted across various industries, including pharmaceuticals, biotechnology, academic research, clinical diagnostics, and forensic sciences. This broad application range contributes to the substantial market share of PCR instruments.
““The Asia Pacific region is grows at the highest CAGR in the gene expression analysis market during the forecast period of 2024-2029.”
The Asia Pacific region is expected to grow at the highest growth rate during the forecast period. This region is s anticipated to experience rapid growth, fueled by expanding proteomics and genomics research, augmented research funding, amplified investments from pharmaceutical and biotechnology enterprises, and rising awareness surrounding personalized therapeutics. India and China are expected to display the highest growth in the Asia Pacific region, particularly due to the rise in affordability and awareness related to the benefits of diagnosis.
The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 70% and Demand Side 30%
• By Designation: Managers - 45%, CXOs and Directors - 30%, and Executives- 25%
• By Region: North America -45%, Europe -20%, Asia-Pacific -20%, Latin America -10%, Middle East & Africa- 5%
List of Companies Profiled in the Report:
• Thermo Fisher Scientific Inc (US)
• Bio-Rad Laboratories Inc. (US)
• Illumina Inc (US)
• QIAGEN (Netherlands)
• F. Hoffmann-La Roche (Switzerland)
• Revvity (US)
• PacBio (US)
• Agilent Technologies Inc (US)
• Oxford Gene Technology IP Limited (UK)
• BGI (China)
• Eurofins Scientific (Luxembourg)
• Standard BioTools (US)
• Oxford Nanopore Technologies plc (UK)
• GenScript (US)
• Takara Bio Inc (Japan)
• 10x Genomics (US)
• Zymo Research Corporation (US)
• Twist Bioscience (US)
• Promega Corporation (US)
• LGC Limited (UK)
• CD Genomics (US)
• NanoString Technologies Inc. (US)
• BioSpyder, Inc (US)
• Integrated DNA Technologies, Inc (US)
• New England Biolabs (US).

Research Coverage:
This research report categorizes the gene expression analysis market by product & service (instruments, reagents & consumables and services (gene expression analysis service and bioinformatics service)), application (clinical diagnostics, drug discovery & development, and other applications (developmental biology, pharmacogenomics, environmental response, forensic research, agricultural research)) , end user (pharmaceutical & biotechnology companies, academic & research institutes, and other end users (clinical laboratories, CROs, forensic laboratories, agricultural & environmental organizations)), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and trends influencing the growth of the gene expression analysis market. The report conducts in-depth analysis of major industry players, offering insights into their business profiles, product/service offerings, and strategic initiatives including collaborations, partnerships, expansions, agreements, acquisitions, and recent developments within the gene expression analysis market. Furthermore, it encompasses competitive analysis of leading players as well as emerging startups within the gene expression analysis market ecosystem.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall gene expression analysis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
• Analysis of key drivers (Advancement in gene editing technologies, increasing funding initiatives for genomic research, growing preference for therapeutic application, declining sequencing cost), restraints (high cost of instruments & consumables, concerns associated with data privacy and security), opportunities (application expansion across non-medical fields, machine learning and ai, growing focus on single-cell analysis), and challenges (prolonged timelines for approval, data interpretation challenges) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on newly launched products of the gene expression analysis market
• Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products/services, untapped geographies, recent developments, and investments in the gene expression analysis market
• Competitive Assessment: Thermo Fisher Scientific Inc (US), Bio-Rad Laboratories Inc. (US), Illumina Inc (US), QIAGEN (Netherlands), F. Hoffmann-La Roche (Switzerland), Revvity (US), PacBio (US), Agilent Technologies Inc (US), Oxford Gene Technology IP Limited (UK), BGI (China), Eurofins Scientific (Luxembourg), Standard BioTools (US), Oxford Nanopore Technologies plc (UK), GenScript (US), Takara Bio Inc (Japan), 10x Genomics (US), Zymo Research Corporation (US), Twist Bioscience (US), Promega Corporation (US), LGC Limited (UK), CD Genomics (US), NanoString Technologies Inc. (US), BioSpyder, Inc (US), Integrated DNA Technologies, Inc (US) and New England Biolabs (US), among others in the market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（バイオ薬物）の最新刊レポート

MarketsandMarkets社のBiotechnology分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（バイオ薬物）の最新刊レポート

MarketsandMarkets社のBiotechnology分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?